JAGX · Jaguar Health Inc
United States · RS rating 9 · As of 2026-11-03
| Price | 0.56 USD |
|---|---|
| 1-day change | -36.9% |
| RS rating (overall / 1M / 3M / 12M) | 9 / 1 / 10 / 12 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 28 / 48 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | +96.7% |
| Sales growth Q/Q | +4.9% |
| Distance from 52-week high | +98.4% |
| Market cap (USD) | $5.1M |